Tesamorelin Canada: Product Specifications and Research Context
5 mg and 10 mg lyophilized tesamorelin peptide for controlled laboratory research
A 44-residue GHRH analogue with an N-terminal trans-3-hexenoyl modification. Not for human or veterinary use.
Tesamorelin Mechanism and Current Evidence
GHRH receptor signalling and evidence boundaries
Primary research: randomized tesamorelin trial · placebo-controlled trial with safety extension · visceral and liver-fat trial
Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone, GHRH(1-44). The trans-3-hexenoyl group at the N-terminus changes peptide stability while retaining the full 44-residue backbone.
In research models, tesamorelin binds the GHRH receptor on pituitary somatotroph cells and activates Gs-coupled cyclic AMP signalling. The pathway can stimulate endogenous growth-hormone release and downstream IGF-1 responses. Researchers measure receptor activation, cyclic AMP, GH, IGF-1 and metabolic endpoints according to the study model.
Controlled human trials examined authorized tesamorelin formulations in defined populations with HIV-associated abdominal fat accumulation. Falutz and colleagues evaluated visceral adipose tissue and IGF-1 outcomes, while Stanley and colleagues examined hepatic lipid endpoints. Those findings apply to the tested formulation, population and protocol. They do not establish the identity or performance of a separate research vial.
| Evidence level | Common measurements | Key limitation |
|---|---|---|
| Receptor and cell models | Binding, cyclic AMP and signalling markers | Cell results do not predict a full-organism response on their own |
| Preclinical models | GH/IGF-1 axis and metabolic endpoints | Species and protocol differences limit translation |
| Controlled human trials | Visceral adipose tissue and hepatic lipid measures | Results apply to the tested medicine and participant group |
Purity, Batch COA and Third-Party Testing
Use the report tied to the vial lot
Anglo Peptides lists tesamorelin at 99% or greater HPLC purity and provides available third-party batch reports through the Certificate of Analysis page. Match the product, lot and test date before using a report in laboratory records.
HPLC estimates chromatographic purity under the stated method. It does not prove sequence identity, nominal vial content, sterility, endotoxin level, biological activity, efficacy or safety. A research protocol may require orthogonal identity and content testing.
| Analytical question | Relevant evidence |
|---|---|
| Relative chromatographic purity | HPLC result and method conditions |
| Molecular identity | Mass spectrometry or another orthogonal identity method |
| Amount in the vial | Quantitative content or fill assay |
| Microbiological status | Sterility and endotoxin tests when the study requires them |
Buy Tesamorelin Canada: Forms, Strengths and Comparisons
Current vial format and related GHRH research analogues
This listing supplies tesamorelin as 5 mg and 10 mg lyophilized vials. The vial strength states nominal peptide content; purity remains a separate analytical result on the batch COA. Check the live selector above for current Canadian-dollar price and stock.
Researchers comparing tesamorelin peptide Canada options with a sermorelin research peptide Canada listing or CJC-1295 without DAC should account for sequence length and stabilization method. These compounds belong to the GHRH analogue research class, but they are not interchangeable forms.
| Research compound | Backbone | Stabilization approach |
|---|---|---|
| Tesamorelin | GHRH(1-44) | N-terminal trans-3-hexenoyl modification |
| Sermorelin | GHRH(1-29) | Short native active fragment |
| CJC-1295 without DAC | Modified GHRH(1-29) | Amino-acid substitutions designed to resist enzymatic degradation |
Reconstitution, Stability and Laboratory Storage in Canada
Record the conditions that affect the prepared sample
Follow the vial label, batch documentation and supplier instructions. Keep lyophilized material protected from heat, moisture and light, and document storage conditions from receipt through study completion.
Reconstituted stability depends on solvent, pH, concentration, container, temperature, light exposure, handling and microbial control. Researchers should use stability data that match the prepared sample rather than applying a universal beyond-use period.
The peptide calculator supports concentration and volume arithmetic. It does not validate solubility, stability, sterility or study suitability.
Research navigation: Anglo Peptides Canada · Buy Peptides Canada · Certificate of Analysis · Peptide calculator · CJC-1295 (No DAC) · Ipamorelin · Sermorelin
Research use only: This product is not intended for human consumption, diagnosis, treatment or veterinary use. Researchers remain responsible for institutional approval, legal compliance, study design and safe laboratory handling.







Mike D. –
First time trying tesamorelin and went with Anglo based on a recommendation. Fast shipping, came well packaged, dissolved perfectly. Will be ordering again once I run through this vial.
Hua Lin –
Shipped same day, arrived next day. Clean powder, easy reconstitution. Really happy with the quality and the service from Anglo.
Nadia B. –
Really happy with this purchase. Tesamorelin from Anglo is great quality. Came same day I ordered, dissolved perfectly. Will be back for sure.
Luca W. –
Tesamorelin from a Canadian manufacturer is exactly what I was looking for. Reconstituted cleanly, COA from Janoshik Labs confirms the purity claims. Fast shipping to BC.
Andrew R. –
Great product at a fair price. Had it within 48 hours of ordering. Vial was well sealed, powder looked perfect. Anglo is now my go-to for everything.
Nora K. –
Fourth order of Tesamorelin from Anglo. Quality never wavers. Same-day Xpresspost and arrives cold-packed. The consistency here is what keeps me coming back.